CD4+ T cell matters in tumor immunity
- PMID: 12962272
- DOI: 10.1080/08830180305220
CD4+ T cell matters in tumor immunity
Abstract
CD4+ T cells have been shown to be able to affect tumor growth through both direct and indirect means. In addition, a requirement has been demonstrated for CD4+ T cells in the regulation and induction of T cell memory, and CD4+ suppressor T cells have been identified, stressing a role for CD4+ T cells in the induction and maintenance of antitumor immune responses. A review of the involvement of CD4+ T cells at different stages of tumor immunity is provided, and based on these data we discuss how CD4+ T cell response induction could be incorporated into tumor immunotherapy strategies.
Similar articles
-
CD4+ T lymphocytes: a critical component of antitumor immunity.Cancer Invest. 2005;23(5):413-9. Cancer Invest. 2005. PMID: 16193641 Review.
-
IFN-gamma-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+ T cells requires tumor responsiveness to IFN-gamma.J Immunol. 2001 Feb 15;166(4):2276-82. doi: 10.4049/jimmunol.166.4.2276. J Immunol. 2001. PMID: 11160282
-
Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.J Immunother. 2011 Jan;34(1):1-15. doi: 10.1097/CJI.0b013e3181f7dbe8. J Immunother. 2011. PMID: 21150709
-
Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.Clin Cancer Res. 2008 Jan 1;14(1):178-87. doi: 10.1158/1078-0432.CCR-07-1880. Clin Cancer Res. 2008. PMID: 18172269 Clinical Trial.
-
Role of CD4+ T lymphocytes in antitumor immunity.Adv Cancer Res. 2003;87:195-249. doi: 10.1016/s0065-230x(03)87298-6. Adv Cancer Res. 2003. PMID: 12641277 Review. No abstract available.
Cited by
-
Combined influence of adjuvant therapy and interval after surgery on peripheral CD4(+) T lymphocytes in patients with esophageal squamous cell carcinoma.Exp Ther Med. 2010 Jan;1(1):113-120. doi: 10.3892/etm_00000020. Epub 2010 Jan 1. Exp Ther Med. 2010. PMID: 23136603 Free PMC article.
-
Selective cancer-germline gene expression in pediatric brain tumors.J Neurooncol. 2008 Jul;88(3):273-80. doi: 10.1007/s11060-008-9577-6. Epub 2008 Apr 9. J Neurooncol. 2008. PMID: 18398575 Free PMC article.
-
Targets for active immunotherapy against pediatric solid tumors.Cancer Immunol Immunother. 2009 Jun;58(6):831-41. doi: 10.1007/s00262-008-0619-x. Epub 2008 Nov 14. Cancer Immunol Immunother. 2009. PMID: 19009292 Free PMC article. Review.
-
CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA.J Virol. 2011 Jul;85(14):7216-24. doi: 10.1128/JVI.00543-11. Epub 2011 May 18. J Virol. 2011. PMID: 21593176 Free PMC article.
-
Immunogenicity of targeted lentivectors.Oncotarget. 2014 Feb 15;5(3):704-15. doi: 10.18632/oncotarget.1680. Oncotarget. 2014. PMID: 24519916 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials